CN Bio Innovations, an expert in developing human biomimetic platforms to test and develop therapeutics for liver diseases and infection, is pleased to announce that it has embarked on a research collaboration with RNAi-based therapeutics company, Benitec Biopharma Limited (ASX:BLT).